Cite

HARVARD Citation

    Liu, Y. et al. (n.d.). Modulation of circulating protein biomarkers following TRC105 (anti‐endoglin antibody) treatment in patients with advanced cancer. Cancer medicine. pp. 580-591. [Online]. 
  
Back to record